Hyperspectral imaging for the detection of glioblastoma tumor cells in h&e slides using convolutional neural networks

95Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.

Abstract

Hyperspectral imaging (HSI) technology has demonstrated potential to provide useful information about the chemical composition of tissue and its morphological features in a single image modality. Deep learning (DL) techniques have demonstrated the ability of automatic feature extraction from data for a successful classification. In this study, we exploit HSI and DL for the automatic differentiation of glioblastoma (GB) and non-tumor tissue on hematoxylin and eosin (H&E) stained histological slides of human brain tissue. GB detection is a challenging application, showing high heterogeneity in the cellular morphology across different patients. We employed an HIS microscope, with a spectral range from 400 to 1000 nm, to collect 517 HS cubes from 13 GB patients using 20 ✕ magnification. Using a convolutional neural network (CNN), we were able to automatically detect GB within the pathological slides, achieving average sensitivity and specificity values of 88% and 77%, respectively, representing an improvement of 7% and 8% respectively, as compared to the results obtained using RGB (red, green, and blue) images. This study demonstrates that the combination of hyperspectral microscopic imaging and deep learning is a promising tool for future computational pathologies.

Cite

CITATION STYLE

APA

Ortega, S., Halicek, M., Fabelo, H., Camacho, R., Plaza De La Luz, M., Godtliebsen, F., … Fei, B. (2020). Hyperspectral imaging for the detection of glioblastoma tumor cells in h&e slides using convolutional neural networks. Sensors (Switzerland), 20(7). https://doi.org/10.3390/s20071911

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free